IDT vs PHI
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
IDT · IDT Corp$73.72 ▼ 1.56%
PHI · PLDT$14.97 ▲ 0.94%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- IDT +50.7%
- PHI -27.9%
Head to head
| Metric | IDT | PHI |
|---|---|---|
| Price | $73.72 | $14.97 |
| Change today | ▼ 1.56% | ▲ 0.94% |
| Market cap | $1.83B | $3.23B |
| Return, 3 months | +8.0% | -19.8% |
| Return, year to date | +44.5% | -25.6% |
| Return, 1 year | +48.8% | -28.0% |
| P/E (TTM) | 21.3 | 7.8 |
| P/B | 4.9 | 1.6 |
| P/E percentile vs own 5y | 83rd | 12th |
| Dividend yield | 0.35% | 9.81% |
| Revenue growth (YoY, latest qtr) | +7.1% | +0.9% |
| Net profit growth (YoY) | +39.7% | -15.0% |
| Gross margin | 38.3% | 85.8% |
| Operating margin | 9.5% | 24.2% |
| Net margin | 6.7% | 12.0% |
| Return on equity | 25.4% | 21.4% |
| Analyst target vs. price | +15.3% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 30 | 28 |
| 30-day volatility | 27.3% | 43.6% |
| Max drawdown, 1 year | -12.7% | -34.6% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PHI is the largest of the group by market value.
- IDT has returned the most over the past year.
- PHI carries the lowest trailing P/E.
- PHI pays the highest dividend yield.
- IDT is growing revenue fastest.
- PHI keeps the most profit per dollar of sales.
- IDT has been the calmest stock over the last 30 days.